🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
This phase II trial studies how well abatacept, ixazomib citrate, and dexam...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2018-09-11
Trial ID
NCT03457142
Treatments Being Tested
Ever since the biotherapy agents have entered the market, the recommended t...
Status
Completed
Location
CHU Pitié Salpêtrière
Start Date
2012-04
Trial ID
NCT01557374
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics, safe...
Status
Completed
Location
Local Institution
Start Date
2009-12
Trial ID
NCT01001832
Treatments Being Tested
The study hypothesis is that SC abatacept is safe and shows evidence of eff...
Status
Completed
Location
Arthritis Associates of Southern California
Start Date
2014-09
Trial ID
NCT02161406
The study is a two-arm, multicenter, double-blinded clinical trial testing ...
Status
Active Not Recruiting
Location
Childrens Hospital of Orange County
Start Date
2023-10-30
Trial ID
NCT03929601
Treatments Being Tested
Abatacept Registry in Taiwan...
Status
Completed
Location
Local Institution
Start Date
2014-08-06
Trial ID
NCT02335606
The primary purpose of this pilot study is to evaluate the efficacy and saf...
Status
Withdrawn
Location
Cleveland Clinic
Start Date
2013-11
Trial ID
NCT02027298
Treatments Being Tested
The primary purpose of the protocol is to describe the pharmacokinetics of ...
Status
Completed
Location
Rheumatology Associates Of North Alabama, P.C.
Start Date
2013-07
Trial ID
NCT01890473
Treatments Being Tested
The purpose of this study is to determine whether a weekly subcutaneous dos...
Status
Completed
Location
Rheumatology Associates, Pc
Start Date
2008-01
Trial ID
NCT00559585
Treatments Being Tested